p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells.
10.4196/kjpp.2016.20.5.487
- Author:
Mohan SHRESTHA
1
;
Pil Hoon PARK
Author Information
1. College of Pharmacy, Yeungnam University, Gyeongsan 38541, Korea. parkp@yu.ac.kr
- Publication Type:Original Article
- Keywords:
Apoptosis;
Cancer;
Cell cycle;
Leptin;
p53
- MeSH:
Adipokines;
Adipose Tissue;
Apoptosis;
Breast Neoplasms*;
Breast*;
Caspase 3;
Cell Cycle;
Gene Silencing;
Genes, Tumor Suppressor;
Leptin;
RNA, Messenger;
RNA, Small Interfering;
Ubiquitin;
Ubiquitination
- From:The Korean Journal of Physiology and Pharmacology
2016;20(5):487-498
- CountryRepublic of Korea
- Language:English
-
Abstract:
Leptin, an adipokine predominantly produced from adipose tissue, is well known to induce tumor growth. However, underlying molecular mechanisms are not established yet. While p53 has long been well recognized as a potent tumor suppressor gene, accumulating evidence has also indicated its potential role in growth and survival of cancer cells depending on experimental environments. In the present study, we examined if p53 signaling is implicated in leptin-induced growth of cancer cells. Herein, we demonstrated that leptin treatment significantly increased p53 protein expression in both hepatic (HepG2) and breast (MCF-7) cancer cells without significant effect on mRNA expression. Enhanced p53 expression by leptin was mediated via modulation of ubiquitination, in particular ubiquitin specific protease 2 (USP2)-dependent manner. Furthermore, gene silencing of p53 by small interfering RNA (siRNA) suppressed leptin-induced growth of hepatic and breast cancer cells, indicating the role of p53 signaling in tumor growth by leptin. In addition, we also showed that knockdown of p53 restored suppression of caspase-3 activity by leptin through modulating Bax expression and prevented leptin-induced cell cycle progression, implying the involvement of p53 signaling in the regulation of both apoptosis and cell cycle progression in cancer cells treated with leptin. Taken together, the results in the present study demonstrated the potential role of p53 signaling in leptin-induced tumor growth.
